News from

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2671 Results
Gene therapy trial sees massive improvement in vision
Closeup view of an eyeball with a vision test graphic.

Image: iStock/murat4art

Gene therapy trial sees massive improvement in vision

Patients with a rare disease affecting their sight have experienced quick vision improvements that sustained for the full yearlong Penn Medicine study, with some experiencing a 10,000-fold improvement in their vision.

Meagan Raeke

Weight management drug does not increase risk of depression or suicidal behavior
A person opening the top of a semaglutide prescription pen.

Image: iStock/imyskin

Weight management drug does not increase risk of depression or suicidal behavior

In new clinical trials, researchers from Penn Medicine find that for people without known major psychopathology, taking semaglutide for weight loss are at no increased risk of mental health issues.

From Penn Medicine News

Keeping calm in case of catastrophe
A group of Penn Medicine emergency responders with face masks look over plans during an emergency drill.

Emergency medicine staff get a training over breakfast on how to care for victims of an explosion.

(Image: Courtesy of Penn Medicine News)

Keeping calm in case of catastrophe

How emergency medical teams at Penn Medicine build the playbook for disaster preparedness.

Kelsey Geesler

Combo immunotherapy produces distinct waves of cancer-fighting T cells
T cells attacking a cancer cell.

Image: iStock/Andrea Danti

Combo immunotherapy produces distinct waves of cancer-fighting T cells

Researchers from Penn’s Abramson Cancer Center have found that a novel tool that tracks immune health over time has revealed new insights on immune cell activation.

Meagan Raeke

Understanding the cellular mechanisms driving solid tumors’ robust defense system
A 3D rendering of the tumor microenvironment with cancer cells, T-Cells, nanoparticles, cancer associated fibroblast layer of tumor microenvironment normal cells, molecules, and blood vessels.

In a collaborative interdisciplinary study, Michael Mitchell of the School of Engineering and Applied Science, Wei Guo of the School of Arts & Sciences, and Drew Weissman of the Perelman School of Medicine show that solid tumors can block drug-delivery mechanisms with a “forcefield-like” effect but certain genetic elements that can effectively “shut down” the forcefield. Their findings hint at new targets for delivering cancer treatments that use the body’s immune system to fight tumors.

(Image: iStock / CIPhotos)

Understanding the cellular mechanisms driving solid tumors’ robust defense system

Researchers from Penn have identified a “forcefield-like” defense system in solid tumors and the genetic elements that can switch it off.
Uncovering new antibiotics inside the human gut
Microscopic rendering of bacterial in the small intestines.

Image: iStock/ChrisChrisW

Uncovering new antibiotics inside the human gut

Researchers from Penn Engineering, led by César de la Fuente, have leveraged AI to discover dozens of potential new antibiotics in the human gut microbiome.

Ian Scheffler

Penn Medicine, 76ers restore community basketball court
Members of the Penn Medicine community play basketball with kids at the Roberto Clemente Park.

The updated Roberto Clemente Park in Fairmount now boasts a freshly repaved court complete with new backboards and nets.

(Image: Courtesy of Penn Medicine News)

Penn Medicine, 76ers restore community basketball court

The latest product of the partnership between two iconic Philadelphia institutions, a newly refurbished court at Roberto Clemente Park will support healthy behavior in the community.

From Penn Medicine News

A modified peptide shows promise for fighting tumors
Tumor microenvironment.

A collaborative team of researchers including scientists from the School of Veterinary Medicine and Perelman School of Medicine show how a modified peptide can successfully target the immunosuppressive tumor microenvironment.

(Image: iStock/Marcin Klapczynski)

A modified peptide shows promise for fighting tumors

Researchers in Penn Vet led a collaborative study that demonstrates how a modified peptide normalizes tumor vasculature and enhances various cancer treatments.
Roy Hamilton encourages tough conversations with grace and compassion
Roy Hamilton.

Roy H. Hamilton, vice dean for Inclusion, Diversity, and Equity.

(Image: Courtesy of Penn Medicine News)

Roy Hamilton encourages tough conversations with grace and compassion

Hamilton, Penn Medicine’s new vice dean for Inclusion, Diversity, and Equity, is dedicating his third decade at the Perelman School of Medicine to making academia a safe, supportive space for students and colleagues alike.

Meredith Mann